1. Noradrenaline Excitations: Neuronal, not Vascular
- Author
-
Johnson Es and Brawley P
- Subjects
Serotonin ,medicine.medical_specialty ,medicine.drug_class ,Central nervous system ,Action Potentials ,General Biochemistry, Genetics and Molecular Biology ,Norepinephrine ,Methoxyflurane ,Internal medicine ,medicine ,Animals ,Vasoconstrictor Agents ,Neurons ,CATS ,Chemistry ,Brain ,Depolarization ,General Medicine ,Hypoxia (medical) ,Endocrinology ,medicine.anatomical_structure ,Barbiturate ,Cerebrovascular Circulation ,medicine.symptom ,Halothane ,Vasoconstriction ,medicine.drug - Abstract
STONE1 suggested that noradrenaline (NA) excitations of central nervous system (CNS) neurones may be indirect effects due to localized vascular changes causing hypoxia, because (1) he found that iontophoretic application of noradrenaline to small mesenteric vessels caused vasoconstriction with a latency and time-course comparable to the excitant effects of noradrenaline on CNS neurones; (2) hypoxia was shown by Lorente de No2 to cause depolarization in nerve fibres; (3) halothane is known to enhance the response of small blood vessels to catecholamines3; (4) Johnson et al.4,5 reported that noradrenaline excitation of cortical neurones occurred predominantly in cats under halothane anaesthesia and less frequently in those anaesthetized with barbiturate; and (5) Phillis and York6 obtained fewer noradrenaline excitations using methoxyflurane, which diminishes peripheral blood vessel sensitivity to catecholamines.
- Published
- 1973
- Full Text
- View/download PDF